folfirinox
Showing 26 - 46 of 46
Locally Advanced and Metastatic Pancreatic Cancer Trial in Shanghai (PD-L1/CTLA4 BsAb, GP, FOLFIRINOX)
Recruiting
- Locally Advanced and Metastatic Pancreatic Cancer
- PD-L1/CTLA4 BsAb
- +2 more
-
Shanghai, Shanghai, ChinaChanghai hospital
Aug 3, 2021
ICC, Metastatic Cancer Trial in Guangzhou (Folfirinox, Sintilimab)
Withdrawn
- ICC
- Metastatic Cancer
- Folfirinox
- Sintilimab
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
Feb 1, 2021
Pancreatic Adenocarcinoma Trial in Philadelphia (Gemcitabine, Abraxane, FOLFIRINOX)
Completed
- Pancreatic Adenocarcinoma
- Gemcitabine
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 24, 2021
Cholangiocarcinoma Trial in Amsterdam (FOLFIRINOX)
Completed
- Cholangiocarcinoma
- FOLFIRINOX
-
Amsterdam, NetherlandsAcademic medical center Amsterdam
Mar 6, 2020
Metastatic Pancreatic Adenocarcinoma Trial in San Francisco, Baltimore, Saint Louis (Ipilimumab, Vaccine, FOLFIRINOX)
Completed
- Metastatic Pancreatic Adenocarcinoma
- Ipilimumab
- +2 more
-
San Francisco, California
- +2 more
May 5, 2020
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Israel, United States (siG12D-LODER, Gemcitabine+nab-Paclitaxel,
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Cancer
- siG12D-LODER
- +2 more
-
Hackensack, New Jersey
- +8 more
Jun 30, 2021
Pancreatic Cancer Trial in Ann Arbor (drug, radiation, procedure)
Completed
- Pancreatic Cancer
- FOLFIRINOX
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Oct 29, 2019
Pancreatic Cancer Non-resectable Trial in Louisville (Folfirinox, Stereotactic Body Radiation Therapy)
Recruiting
- Pancreatic Cancer Non-resectable
- Folfirinox
- Stereotactic Body Radiation Therapy
-
Louisville, Kentucky
- +1 more
Oct 24, 2019
Neoadjuvant Chemotherapy in Borderline Resectable and Locally
Recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +3 more
- Folfirinox
-
Oslo, NorwayOslo University Hospital
Jun 5, 2020
Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Indianapolis (Stereotactic Body Radiation Therapy (SBRT), FOLFIRINOX)
Withdrawn
- Pancreatic Cancer
- Pancreatic Adenocarcinoma
- Stereotactic Body Radiation Therapy (SBRT)
- FOLFIRINOX
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Oct 15, 2019
Pancreatic Cancer Trial in Guangzhou (Folfirinox)
Recruiting
- Pancreatic Cancer
- Folfirinox
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 11, 2019
Hepatocellular Carcinoma Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol, Sorafenib)
Unknown status
- Hepatocellular Carcinoma
- Hepatic arterial infusion chemotherapy
- +3 more
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
Jan 19, 2019
Pancreatic Adenocarcinoma Trial (FOLFIRINOX, Electroporation)
Withdrawn
- Pancreatic Adenocarcinoma
- FOLFIRINOX
- Electroporation
- (no location specified)
Oct 12, 2018
Pancreatic Cancer, Pancreatic Carcinoma Non-resectable, Locally Advanced Malignant Tumor Trial in United States (drug,
Terminated
- Pancreatic Cancer
- +2 more
- FOLFIRINOX
- +5 more
-
Tucson, Arizona
- +31 more
May 26, 2020
Prognostic Factors in Advanced Pancreatic Cancer Patients
Completed
- Pancreatic Cancer Non-resectable
- FOLFIRINOX
-
Ponderano, Biella, Italy
- +6 more
Jul 6, 2018
Locally Advanced Pancreatic Cancer Trial in Amsterdam, Utrecht (Radiofrequency ablation (RFA), FOLFIRINOX, Nab-paclitaxel plus
Unknown status
- Locally Advanced Pancreatic Cancer
- Radiofrequency ablation (RFA)
- +3 more
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Sep 28, 2018
Pancreatic Cancer Trial in Chapel Hill (FOLFIRINOX)
Terminated
- Pancreatic Cancer
- FOLFIRINOX
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Sep 7, 2017
Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in New Haven (Folfirinox)
Completed
- Metastatic Pancreatic Cancer
- Pancreatic Cancer
- Folfirinox
-
New Haven, ConnecticutSmilow Cancer Center
Aug 28, 2017
Resectable Pancreatic Cancer, Pancreatic Ductal Carcinoma Trial in Boston (FOLFIRINOX, Gemcitabine/nab-Paclitaxel, Radiation
Terminated
- Resectable Pancreatic Cancer
- Pancreatic Ductal Carcinoma
- FOLFIRINOX
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 10, 2017
Colorectal Cancer, Liver Metastases, Chemo Trial in Montpellier (FOLFIRI, FOLFOX-4, FOLFIRI-HD)
Completed
- Colorectal Cancer
- +2 more
- FOLFIRI
- +4 more
-
Montpellier, FranceCRLC Val d'Aurelle
Jun 15, 2010